A seris of coorta carcinomas (n = 49) resected from patients with known chinical outcomes were analysed for E-caderin expression using in situ hybridisation to measure mRNA. Patients surviving 5 years or longer (n = 31) exhibited significantly higher kvels of E-cadherin mRNA than those surviving less than 5 years (n = 18, P = 0.003). These peiminary reslts from this small sample suggest that E-cadherin expression may be a useful prognostic marker in colorectal cancer patients.Keywords: colorectal carcinomas; E-cadherin; prognosis Colorectal cancer is one of the most common malignances in the developed world and remains a major publc health problem (King's Fund Forum, 1990). Pathological staging, using the Dukes claation, offers an accurate guide to the outcome of patients who have undergone surgicl resection (Deans et al., 1992(Deans et al., , 1993 (Frixen et al., 1991). A large number of fresh human cancers also have been analysed for E-cadherin expression by immunohistochemistry (Takeichi, 1993), including clinical material denved from patients with colorectal cancer (Dorudi et al., 1993;Kinsella et al., 1993;Nigam et al., 1993).Generally, these investigations have revealed an inverse relationship between E-cadherin expression and tumour grade, with poorly differentiated tumours exhibiting reduced or absent immunoreactivity (Takeichi, 1993). Although downregulation of E-cadherin has been observed in undifferentiated (Dorudi et al., 1993;Kinsella et al., 1993;Nigam et al., 1993) and advanced colorectal carcinomas (Dorudi et al., 1993), no study has yet examined the possible relationship between expression of this cell adhesion molecule and prognosis in colorectal cancer. Such a relationship, however, has been exaied in three other tumour types: bladder, head and neck and gastric cancer (Brnguier et al., 1993; Mattijsen et al., 1993;Mayer et al., 1993). Uniformly, these authors all reported that a reduced level of E-cadherin was correlated significntly with poor prognosis, but the studies all used frozen material for E-cadherin immunohistochemistry, tended not to have stage-matched material and had lmited follow-up data (of less than 5 years) (Bringuier et al., 1993; Mattijsen et al., 1993;Mayer et al., 1993).Previously we showed that in colorectal cancer there is a good correlation between the presence of E-cadherin mRNA and protein (Dorudi et al., 1993